Fatal hemolytic disease of the newborn caused by an antibody to KEAL, a new low-prevalence Kell blood group antigen

Transfusion. 2017 Jan;57(1):217-218. doi: 10.1111/trf.13852. Epub 2016 Sep 28.

Affiliations

¹ Red Cross Blood Service of Baden-Württemberg-Hessen, Institute Baden-Baden, Baden-Baden, Germany.
² Institute of Transfusion Medicine and Immunology, Heidelberg University, Medical Faculty Mannheim, German Red Cross Blood Service Baden-Württemberg-Hessen, Mannheim, Germany.
³ Klinikum Stuttgart, Institute of Transfusion Medicine.
⁴ Olgahospital, Klinikum Stuttgart, Stuttgart, Germany.
⁵ New York Blood Center, New York, New York.

PMID: 27679424
DOI: 10.1111/trf.13852

No abstract available

MeSH terms

Adult
Antibodies / immunology*
Erythroblastosis, Fetal / etiology*
Erythroblastosis, Fetal / genetics
Erythroblastosis, Fetal / immunology
Exons / genetics
Female
Humans
Kell Blood-Group System / genetics*
Kell Blood-Group System / immunology
Male
Pedigree

Substances

Antibodies
Kell Blood-Group System